Previously we demonstrated that oncogenic signalling downstream of the EGFR kinase in a lung cancer mouse model and in human cancer cell lines contributed to immune evasion through the activation of the PD-1:PD-L1 immune checkpoint. The gene discussed is CD274; the disease is cancer.